Stay updated on Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.

Latest updates to the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNo significant changes detected; the Study Details page content appears unchanged.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check42 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check50 days agoChange DetectedPage now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); no new people, prices, or availability data are introduced.SummaryDifference0.3%

- Check64 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as information related to diabetes prevention and drug safety. Notably, the revision number has been updated to v3.0.0.SummaryDifference3%

Stay in the know with updates to Dulaglutide Doses in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dulaglutide Doses in Type 2 Diabetes Clinical Trial page.